Expectant mothers caught between a drug company, Medicaid and the state

KV Pharmaceutical Co. chares over $500 per injection for its drug Makena – – the first FDA approved drug for preventing preterm births.  The alternative drug, 17P, costs about $20 per injection but key components are made in China, which, when combined with other factors, makes 17P less safe to use.

KV filed suit against the Illinois Department of Healthcare and Family Services for failing to use Medicaid funds to pay for the drug.

KV has filed for bankruptcy relief, Medicaid says there are no funds to pay for the drug and insurance companies say 17P is just as good. Unfortunately, it is expectant mothers and their unborn babies that are suffering from this battle.

Read the entire story here “Pre-term birth drug maker to Illinois: Pay up”

Speak Your Mind

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.